Diabetes and Obesity Treatment at Risk: FDA’s Warning on Semaglutide’s Impact in Treatment”
Doctors primarily use semaglutide as a key drug for the treatment of obesity and diabetes. However, in a noteworthy development. FDA issued a warning on Tuesday specifically regarding the compounded version of the drug semaglutide. Compounding “is the process of combining, mixing, or altering ingredients to create a medication tailored to the needs of an … Read more